(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are LAVIDE HOLDING, NORDIC NANOVECTOR, and TECHSTEP.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
LAVIDE HOLDING (LVIDE.AS) | 0.30 | 20% | 2023-06-06 11:03:12 |
NORDIC NANOVECTOR (NANOV.OL) | 0.93 | 16.83% | 2023-06-06 11:31:52 |
TECHSTEP (TECH.OL) | 19.40 | 9.59% | 2023-06-06 11:34:39 |
OCEANTEAM (OTS.OL) | 1.62 | 9.09% | 2023-06-06 11:32:16 |
DGB GROUP N.V. (DGB.AS) | 0.58 | 8.61% | 2023-06-06 11:01:47 |
SPBK1 RINGERIKE (RING.OL) | 326.00 | 6.54% | 2023-06-06 08:34:10 |
ATLANTIC SAPPHIRE (ASA.OL) | 6.33 | 6.03% | 2023-06-06 11:20:34 |
BALYO (BALYO.PA) | 0.56 | 5.85% | 2023-06-06 11:45:10 |
AKVA GROUP (AKVA.OL) | 65.40 | 5.48% | 2023-06-06 11:20:17 |
ARCTICZYMES TECHNO (AZT.OL) | 42.75 | 5.17% | 2023-06-06 11:20:23 |
The three biggest losers today are FONCIERE EURIS, THUNDERBIRD, and BERGENBIO.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
FONCIERE EURIS (EURS.PA) | 1.46 | -23.96% | 2023-06-06 08:49:22 |
THUNDERBIRD (TBIRD.AS) | 0.06 | -11.76% | 2023-06-06 08:04:36 |
BERGENBIO (BGBIO.OL) | 0.31 | -8.43% | 2023-06-06 11:20:52 |
RALLYE (RAL.PA) | 0.65 | -7.29% | 2023-06-06 11:02:03 |
NHOA (NHOA.PA) | 4.46 | -5.91% | 2023-06-06 11:00:50 |
ALUMEXX N.V. (ALX.AS) | 0.64 | -5.88% | 2023-06-06 11:00:29 |
STOLT-NIELSEN (SNI.OL) | 260.00 | -5.45% | 2023-06-06 11:34:28 |
AIRTHINGS (AIRX.OL) | 2.47 | -5.18% | 2023-06-06 11:20:00 |
BW LPG (BWLPG.OL) | 98.70 | -5% | 2023-06-06 11:21:10 |
ABIVAX (ABVX.PA) | 16.92 | -4.84% | 2023-06-06 11:35:45 |
Winners today
1. LAVIDE HOLDING (LVIDE.AS)
20% Price Change
Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.
AEX-Index ended the session with LAVIDE HOLDING jumping 20% to €0.30 on Tuesday, following the last session’s downward trend. AEX-Index fell 0.15% to €762.22, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LAVIDE HOLDING’s stock is considered to be oversold (<=20).
Moving Average
LAVIDE HOLDING’s worth is way higher than its 50-day moving average of €0.24 and way under its 200-day moving average of €0.35.
More news about LAVIDE HOLDING.
2. NORDIC NANOVECTOR (NANOV.OL)
16.83% Price Change
Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NORDIC NANOVECTOR rising 16.83% to €0.93 on Tuesday, after five consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 1.11% to €1,213.72, after three successive sessions in a row of gains, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-2.88.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -304.6%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC NANOVECTOR’s stock is considered to be oversold (<=20).
Volatility
NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.18%, a negative 0.01%, and a positive 3.34%.
NORDIC NANOVECTOR’s highest amplitude of average volatility was 4.18% (last week), 3.03% (last month), and 3.34% (last quarter).
Volume
Today’s last reported volume for NORDIC NANOVECTOR is 1138000 which is 256.99% above its average volume of 318775.
More news about NORDIC NANOVECTOR.
3. TECHSTEP (TECH.OL)
9.59% Price Change
Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with TECHSTEP rising 9.59% to €19.40 on Tuesday while Oslo Børs Benchmark Index_GI slid 1.11% to €1,213.72.
Earnings Per Share
As for profitability, TECHSTEP has a trailing twelve months EPS of kr-3.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.33%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TECHSTEP’s stock is considered to be oversold (<=20).
Moving Average
TECHSTEP’s worth is way higher than its 50-day moving average of kr14.62 and way higher than its 200-day moving average of kr13.02.
Earnings Before Interest, Taxes, Depreciation, and Amortization
TECHSTEP’s EBITDA is 0.55.
Yearly Top and Bottom Value
TECHSTEP’s stock is valued at kr19.40 at 22:40 EST, way below its 52-week high of kr29.70 and way above its 52-week low of kr1.59.
More news about TECHSTEP.
4. OCEANTEAM (OTS.OL)
9.09% Price Change
Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM jumping 9.09% to €1.62 on Tuesday while Oslo Børs Benchmark Index_GI fell 1.11% to €1,213.72.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.39.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.42%.
Volatility
OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.26%, a negative 0.36%, and a positive 3.25%.
OCEANTEAM’s highest amplitude of average volatility was 5.93% (last week), 4.93% (last month), and 3.25% (last quarter).
Yearly Top and Bottom Value
OCEANTEAM’s stock is valued at kr1.62 at 22:40 EST, way below its 52-week high of kr4.75 and way higher than its 52-week low of kr1.26.
Volume
Today’s last reported volume for OCEANTEAM is 48673 which is 2.18% below its average volume of 49759.
More news about OCEANTEAM.
5. DGB GROUP N.V. (DGB.AS)
8.61% Price Change
DGB Group N.V. invests in, develops, and manages biodiversity and carbon offset, and nature-based projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising the management and use of nature for tackling social and environmental challenges; carbon offsetting projects for reducing carbon footprint of companies; and biodiversity protection and ecosystem services. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Hoofddrop, the Netherlands.
AEX-Index ended the session with DGB GROUP N.V. jumping 8.61% to €0.58 on Tuesday, after two consecutive sessions in a row of losses. AEX-Index slid 0.15% to €762.22, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19%.
More news about DGB GROUP N.V..
6. SPBK1 RINGERIKE (RING.OL)
6.54% Price Change
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Oslo Børs Benchmark Index_GI ended the session with SPBK1 RINGERIKE jumping 6.54% to €326.00 on Tuesday while Oslo Børs Benchmark Index_GI dropped 1.11% to €1,213.72.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr27.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 12.07. Meaning, the purchaser of the share is investing kr12.07 for every norwegian krone of annual earnings.
More news about SPBK1 RINGERIKE.
7. ATLANTIC SAPPHIRE (ASA.OL)
6.03% Price Change
Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.
Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE jumping 6.03% to €6.33 on Tuesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 1.11% to €1,213.72, after three sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.69.
Volatility
ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was 2.94%, 1.41%, and 2.66%.
ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 3.41% (last week), 2.22% (last month), and 2.66% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be oversold (<=20).
More news about ATLANTIC SAPPHIRE.
8. BALYO (BALYO.PA)
5.85% Price Change
Balyo SA designs, develops, and markets material handling robots worldwide. The company offers robotic pallet and reach trucks, tuggers, stackers, counterbalanced stackers, very narrow aisles, and autonomous mobile robots. Its products are used in intelligent pallet detection, barcode scanning, inter-building transport, push button configuration, machine interface, ERP interfacing, and palletizers; and WMS interface and 3D camera applications. The company serves 3PL, automotive, e-commerce, and consumer goods industries. Balyo SA was founded in 2004 and is headquartered in Arcueil, France.
CAC 40 ended the session with BALYO rising 5.85% to €0.56 on Tuesday while CAC 40 rose 0.11% to €7,209.00.
Earnings Per Share
As for profitability, BALYO has a trailing twelve months EPS of €-0.14.
Yearly Top and Bottom Value
BALYO’s stock is valued at €0.56 at 22:40 EST, way under its 52-week high of €0.97 and way higher than its 52-week low of €0.38.
Volume
Today’s last reported volume for BALYO is 152023 which is 4.76% above its average volume of 145102.
Moving Average
BALYO’s worth is above its 50-day moving average of €0.55 and higher than its 200-day moving average of €0.54.
More news about BALYO.
9. AKVA GROUP (AKVA.OL)
5.48% Price Change
AKVA group ASA designs, purchases, manufactures, assembles, sells, and installs technology products; and provides rental and consulting services for the aquaculture industry. The company operates through three segments: Sea Based Technology (SBT), Digital, and Land Based Technology. The SBT segment offers plastic cages, steel cages, fish farming cages, feed barges, feed systems, sensor and camera systems, light systems, net cleaning systems, remotely operating vehicles, and nets and mooring systems under the Polarcirkel, Wavemaster, and Akvasmart hardware brands. This segment also supplies polyethylene boats and pipes to aquaculture and other industries, as well as plastic pen. The Digital segment provides production control, planning, traceability, and ERP software for the aquaculture and fishing industries under the Fishtalk, AKVAconnect, and AKVA Observe. The Land Based Technology segment designs and delivers recirculation systems for land-based fish farming, as well as provides water quality conditions for fresh and seawater operations. AKVA group ASA operates in Norway, Chile, the United Kingdom, Denmark, Canada, and internationally. The company was incorporated in 1982 and is based in Klepp Stasjon, Norway. AKVA group ASA is a subsidiary of Egersund Group AS.
Oslo Børs Benchmark Index_GI ended the session with AKVA GROUP jumping 5.48% to €65.40 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 1.11% to €1,213.72, after three sequential sessions in a row of gains, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, AKVA GROUP has a trailing twelve months EPS of kr-4.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.65%.
More news about AKVA GROUP.
10. ARCTICZYMES TECHNO (AZT.OL)
5.17% Price Change
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Oslo Børs Benchmark Index_GI ended the session with ARCTICZYMES TECHNO rising 5.17% to €42.75 on Tuesday while Oslo Børs Benchmark Index_GI fell 1.11% to €1,213.72.
Earnings Per Share
As for profitability, ARCTICZYMES TECHNO has a trailing twelve months EPS of kr0.34.
PE Ratio
ARCTICZYMES TECHNO has a trailing twelve months price to earnings ratio of 125.74. Meaning, the purchaser of the share is investing kr125.74 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.
More news about ARCTICZYMES TECHNO.
Losers Today
1. FONCIERE EURIS (EURS.PA)
-23.96% Price Change
Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.
CAC 40 ended the session with FONCIERE EURIS falling 23.96% to €1.46 on Tuesday while CAC 40 jumped 0.11% to €7,209.00.
Earnings Per Share
As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-16.41.
Volume
Today’s last reported volume for FONCIERE EURIS is 118 which is 73.36% below its average volume of 443.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FONCIERE EURIS’s stock is considered to be oversold (<=20).
More news about FONCIERE EURIS.
2. THUNDERBIRD (TBIRD.AS)
-11.76% Price Change
Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.
AEX-Index ended the session with THUNDERBIRD falling 11.76% to €0.06 on Tuesday, after two consecutive sessions in a row of losses. AEX-Index dropped 0.15% to €762.22, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.01.
PE Ratio
THUNDERBIRD has a trailing twelve months price to earnings ratio of 6. Meaning, the purchaser of the share is investing €6 for every euro of annual earnings.
More news about THUNDERBIRD.
3. BERGENBIO (BGBIO.OL)
-8.43% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO falling 8.43% to €0.31 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 1.11% to €1,213.72, after three consecutive sessions in a row of gains, on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-3.74.
Volatility
BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.72%, a negative 4.64%, and a positive 8.34%.
BERGENBIO’s highest amplitude of average volatility was 10.35% (last week), 21.25% (last month), and 8.34% (last quarter).
More news about BERGENBIO.
4. RALLYE (RAL.PA)
-7.29% Price Change
Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Latin America mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment and management, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. As of December 31, 2021, Rallye SA operates as a subsidiary of Foncière Euris SA.
CAC 40 ended the session with RALLYE falling 7.29% to €0.65 on Tuesday while CAC 40 rose 0.11% to €7,209.00.
Earnings Per Share
As for profitability, RALLYE has a trailing twelve months EPS of €-4.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.93%.
Moving Average
RALLYE’s value is way under its 50-day moving average of €1.35 and way under its 200-day moving average of €2.43.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, RALLYE’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for RALLYE is 85492 which is 53.4% above its average volume of 55728.
More news about RALLYE.
5. NHOA (NHOA.PA)
-5.91% Price Change
NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.
CAC 40 ended the session with NHOA sliding 5.91% to €4.46 on Tuesday, after five sequential sessions in a row of gains. CAC 40 jumped 0.11% to €7,209.00, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.43%.
Volume
Today’s last reported volume for NHOA is 15396 which is 25.08% below its average volume of 20551.
More news about NHOA.
6. ALUMEXX N.V. (ALX.AS)
-5.88% Price Change
Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.
AEX-Index ended the session with ALUMEXX N.V. falling 5.88% to €0.64 on Tuesday while AEX-Index dropped 0.15% to €762.22.
Earnings Per Share
As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.01.
PE Ratio
ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 64. Meaning, the purchaser of the share is investing €64 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.
More news about ALUMEXX N.V..
7. STOLT-NIELSEN (SNI.OL)
-5.45% Price Change
Stolt-Nielsen Limited provides transportation, storage, and distribution solutions for bulk liquid chemicals, edible oils, acids, and other specialty liquids worldwide. It operates through five segments: Tankers, Terminals, Tank Containers, Stolt Sea Farm, and Stolt-Nielsen Gas. The company also produces, processes, and markets seafood, including turbot and sole; and transports, stores, and distributes chemicals, clean petroleum products, liquefied petroleum gases, vegetable oils, biofuels, and oleochemicals, as well as alternative fuels and feedstocks. In addition, it owns and operates liquid natural gas carriers. The company was founded in 1959 and is based in London, the United Kingdom. Stolt-Nielsen Limited is a subsidiary of Fiducia Ltd.
Oslo Børs Benchmark Index_GI ended the session with STOLT-NIELSEN sliding 5.45% to €260.00 on Tuesday while Oslo Børs Benchmark Index_GI dropped 1.11% to €1,213.72.
Earnings Per Share
As for profitability, STOLT-NIELSEN has a trailing twelve months EPS of kr67.71.
PE Ratio
STOLT-NIELSEN has a trailing twelve months price to earnings ratio of 3.84. Meaning, the purchaser of the share is investing kr3.84 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.43%.
Moving Average
STOLT-NIELSEN’s worth is way below its 50-day moving average of kr306.03 and under its 200-day moving average of kr269.55.
More news about STOLT-NIELSEN.
8. AIRTHINGS (AIRX.OL)
-5.18% Price Change
Airthings ASA, a hardware-enabled software company, develop products and systems for monitoring indoor air quality, radon, and energy efficiency worldwide. It operates through Consumer, Business, and Professional segments. The Consumer segments sells air quality sensors to private customers through retail and e-commerce. Its Business segment provides air quality solutions to schools, office building, and other commercial buildings. The Professional segment sells measurement solutions, which enables inspectors and certified radon professionals to measure, analyze, and report on buildings; and offers rental of products and calibration services. In addition, it offers digital radon detectors as well as smart indoor air quality monitors and solutions. The company provides its products under the View Plus, Wave Plus, Wave Radon, Wave Mini, House Kit, Hub, Corentium Home, Plus, and Pro brands. Airthings ASA was incorporated in 2008 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with AIRTHINGS dropping 5.18% to €2.47 on Tuesday while Oslo Børs Benchmark Index_GI dropped 1.11% to €1,213.72.
Earnings Per Share
As for profitability, AIRTHINGS has a trailing twelve months EPS of kr-0.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.08%.
Moving Average
AIRTHINGS’s worth is under its 50-day moving average of kr2.68 and way under its 200-day moving average of kr3.69.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.4%, now sitting on 35.11M for the twelve trailing months.
Yearly Top and Bottom Value
AIRTHINGS’s stock is valued at kr2.47 at 22:40 EST, way below its 52-week high of kr5.74 and way above its 52-week low of kr2.08.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AIRTHINGS’s stock is considered to be overbought (>=80).
More news about AIRTHINGS.
9. BW LPG (BWLPG.OL)
-5% Price Change
BW LPG Limited, an investment holding company, engages in shipowning and chartering activities worldwide. The company operates through Shipping and Product Services segments. It is involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. The company also offers integrated liquified petroleum gas (LPG) delivery services directly to buyers and receivers. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Oslo Børs Benchmark Index_GI ended the session with BW LPG falling 5% to €98.70 on Tuesday while Oslo Børs Benchmark Index_GI fell 1.11% to €1,213.72.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr24.42.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 4.04. Meaning, the purchaser of the share is investing kr4.04 for every norwegian krone of annual earnings.
More news about BW LPG.
10. ABIVAX (ABVX.PA)
-4.84% Price Change
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that modulate the body's natural immune system to treat patients with chronic inflammatory, infectious, and cancer diseases. The company's products include obefazimod that is in Phase III clinical trials for the treatment of ulcerative colitis; Phase IIb clinical trials for the treatment of Crohn's Disease; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and in a pre-clinical trial for the treatment of Respiratory Syncytial Virus. It also develops ABX 196, an immune enhancer candidate that is in Phase 2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue, influenza, and respiratory syncytial virus. It has license agreement with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
CAC 40 ended the session with ABIVAX sliding 4.84% to €16.92 on Tuesday while CAC 40 rose 0.11% to €7,209.00.
Earnings Per Share
As for profitability, ABIVAX has a trailing twelve months EPS of €-3.17.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -315.24%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABIVAX’s stock is considered to be overbought (>=80).
More news about ABIVAX.
Stay up to date with our winners and losers daily report